EPIX
ESSA Pharma
EPIX
EPIX
Delisted
EPIX was delisted on the 8th of October, 2025.
45 hedge funds and large institutions have $84.1M invested in ESSA Pharma in 2022 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 9 increasing their positions, 17 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
50% less call options, than puts
Call options by funds: $109K | Put options by funds: $216K
53% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 17
Holders
45
Holding in Top 10
–
Calls
$109K
Puts
$216K
Top Buyers
| 1 | +$5.96M | |
| 2 | +$5.04M | |
| 3 | +$3.1M | |
| 4 |
ABG
Ally Bridge Group
New York
|
+$2.05M |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$667K |
Top Sellers
| 1 | -$2.84M | |
| 2 | -$2.39M | |
| 3 | -$1.52M | |
| 4 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
-$760K |
| 5 |
MB
MPM BioImpact
Boston,
Massachusetts
|
-$738K |